TFSA: 3 Healthcare Stocks That Can Make You Filthy Rich

TFSA investors should be on the hunt for the kind of growth offered by healthcare stocks like Knight Therapeutics Inc. (TSX:GUD) in 2020 and beyond.

| More on:

With May in the rear-view mirror, investors are looking ahead to the summer after a hectic spring. At the beginning of the season, the TSX index was rife with discounts. That is not the case in the current environment. Today, I want to look at stocks that are perfect for stashing in a TFSA. I’m still incredibly bullish on healthcare stocks. Let’s explore why.

Healthcare stocks are perfect for a TFSA

In the 2010s, technology and healthcare were the stars of the North American markets. The COVID-19 pandemic has highlighted the need for more investment in this sector across the world. Moreover, demographic shifts in developed countries will see demand increase in this industry. Below are a few healthcare stocks worth stashing in your TFSA before the summer.

Biotherapeutics are one of the fastest-growing sub-sectors in healthcare. A 2017 report from Grand View Research projected that the global biotechnology market would reach US$727 billion by 2025. That would represent a CAGR of 7.4% from the beginning of the forecast period. Cancer therapeutics and biotherapeutics are seeing massive investment, and this should continue to grow this decade. In early 2019, I’d recommended the Vancouver-based biotech stock Zymeworks. The company has since migrated solely to the NYSE, but it rewarded Canadian investors handsomely during its run.

Two therapeutics stocks to hold this decade

HLS Therapeutics is a specialty pharmaceutical company. It acquires and commercializes pharma products in the specialty central nervous system and cardiovascular markets in Canada, the U.S., and Barbados. Shares of HLS Therapeutics have climbed 10% over the past month as of early afternoon trading on June 3.

The company released its first-quarter 2020 results on May 7. Revenue rose to $13.9 million over $13.2 million in the prior year. HLS also reported positive adjusted EBITDA and cash from operations. This healthcare stock also offers a modest quarterly dividend payout of $0.05 per share.

In early March, I’d suggested that Knight Therapeutics (TSX:GUD) was a great addition as the market sell-off worsened. Shares of Knight have climbed 14% over the past three months. On May 29, Knight announced that it expects to release its first-quarter 2020 results on June 26, 2020.

Knight made a big splash in 2019 with its acquisition of the Latin American pharma company Grupo Biotoscana. This has provided the company with a greater worldwide reach. The company has put together a nice streak of record revenues, and this recent acquisition has the potential to extend it further into this decade.

This is a healthcare stock I’m still bullish on in June. Shares last had a favourable price-to-book value of 1.2. Knight has high growth potential going forward.

Bet on health technology this decade

WELL Health Technologies owns and operates a portfolio of primary healthcare facilities. Its shares have shot up 82% in 2020 so far. In the first quarter, WELL achieved record quarterly revenue of $10.2 million — up 38% from the prior year. Its digital services revenue soared 918% year over year to $1.7 million. WELL has offered crucial services during the COVID-19 pandemic, allowing healthcare workers to assist through its telehealth program. This is a stock that has explosive potential going forward.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan owns shares of ZYMEWORKS INC.

More on Investing

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

How to Use Your TFSA to Double Your TFSA Contribution

If you're looking to double up that TFSA contribution, there is one dividend stock I would certainly look to in…

Read more »

Income and growth financial chart
Investing

A Top-Performing U.S. Stock That Canadian Investors Really Should Own

Amazon (NASDAQ:AMZN) is starting to run faster in the AI race, making it a top U.S. pick for 2025.

Read more »

Person uses a tablet in a blurred warehouse as background
Tech Stocks

2 Canadian AI Stocks Poised for Significant Gains

Here are two top AI stocks long-term investors may want to consider before the end of the year.

Read more »

man touches brain to show a good idea
Investing

3 No Brainer Tech Stocks to Buy With $500 Right Now

Here are three no-brainer tech stocks long-term investors on a limited budget may want to consider right now.

Read more »

woman looks at iPhone
Dividend Stocks

Retirees: Is TELUS Stock a Risky Buy?

TELUS stock has long been a strong dividend provider, but what should investors consider now after recent earnings?

Read more »

Concept of multiple streams of income
Dividend Stocks

Is goeasy Stock Still Worth Buying for Growth Potential?

goeasy offers a powerful combination of growth and dividend-based return potential, but it might be less promising for growth alone.

Read more »

A person looks at data on a screen
Dividend Stocks

How to Use Your TFSA to Earn $300 in Monthly Tax-Free Passive Income

If you want monthly passive income, look for a dividend stock that's going to have one solid long-term outlook like…

Read more »

Man holds Canadian dollars in differing amounts
Investing

Is Dollarama Stock a Buy?

Although Dollarama's stock is expensive and has rallied by more than 40% over the last year, is it still worth…

Read more »